Patents by Inventor Fatemeh Akhlaghi

Fatemeh Akhlaghi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10126316
    Abstract: Disclosed is a method of measuring tacrolimus levels in a subject. In exemplary embodiments, the method comprises the steps of: collecting oral fluid from the subject; homogenizing the oral fluid; combining the homogenized oral fluid with a precipitating solvent; separating oral fluid components on a liquid chromatography column by gradient elution with a mixture of a solvent A and a solvent B, wherein the solvent A is about 2 mM ammonium acetate/0.1% (v/v) formic acid in water and solvent B is about 2 mM ammonium acetate/0.1% (v/v) formic acid in MeOH and wherein the amount of solvent B is increased from about 50% (v/v) to about 98% (v/v); and quantifying the amount of tacrolimus in the oral fluid by mass spectrometry.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: November 13, 2018
    Assignee: Rhode Island Council on Postsecondary Education, Statutory Sucessor to the Rhode Island Board of Education, and Rhode Island Board of Governors for Higher Education
    Inventors: Fatemeh Akhlaghi, Mwlod Ghareeb
  • Publication number: 20170276693
    Abstract: Disclosed is a method of measuring tacrolimus levels in a subject. In exemplary embodiments, the method comprises the steps of: collecting oral fluid from the subject; homogenizing the oral fluid; combining the homogenized oral fluid with a precipitating solvent; separating oral fluid components on a liquid chromatography column by gradient elution with a mixture of a solvent A and a solvent B, wherein the solvent A is about 2 mM ammonium acetate/0.1% (v/v) formic acid in water and solvent B is about 2 mM ammonium acetate/0.1% (v/v) formic acid in MeOH and wherein the amount of solvent B is increased from about 50% (v/v) to about 98% (v/v); and determining amount of tacrolimus in the oral fluid by mass spectrometry.
    Type: Application
    Filed: March 22, 2017
    Publication date: September 28, 2017
    Inventors: Fatemeh Akhlaghi, Mwlod Ghareeb
  • Publication number: 20110281369
    Abstract: A method for mass spectrometric analysis of a saliva sample possibly containing mycophenolic acid or its metabolites mycophenolic acid phenyl glucuronide (MPAG) or mycophenolic acid acyl-glucuronide (Acyl-MPAG), including the steps: (a) providing a saliva sample containing one or more drug or metabolites; (b) deproteinating the sample; (c) separating the one or more drug or metabolites from the saliva sample; and (d) analyzing the one or more drug or metabolites using a mass spectrometer. The sample containing one or more MPA or metabolites is obtained from in an oral fluid based biological samples i.e. whole saliva or saliva obtained by chemical or mechanical stimulation or from specific salivary glands. The size of the sample contains one or more MPA or metabolites is at least about 100 microL.
    Type: Application
    Filed: July 25, 2011
    Publication date: November 17, 2011
    Applicant: Board of Governors for Higher Education, State of Rhode Island and Providence Plantations
    Inventors: Fatemeh Akhlaghi, Anisha E. Mendonza
  • Publication number: 20080318322
    Abstract: A method for mass spectrometric analysis of a saliva sample possibly containing mycophenolic acid or its metabolites mycophenolic acid phenyl glucuronide (MPAG) or mycophenolic acid acyl-glucuronide (Acyl-MPAG), including the steps: (a) providing a saliva sample containing one or more drug or metabolites; (b) deproteinating the sample; (c) separating the one or more drug or metabolites from the saliva sample; and (d) analyzing the one or more drug or metabolites using a mass spectrometer. The sample containing one or more MPA or metabolites is obtained from in an oral fluid based biological samples i.e. whole saliva or saliva obtained by chemical or mechanical stimulation or from specific salivary glands. The size of the sample contains one or more MPA or metabolites is at least about 100 microL.
    Type: Application
    Filed: June 30, 2008
    Publication date: December 25, 2008
    Inventors: Fatemeh Akhlaghi, Anisha E. Mendonza
  • Publication number: 20080255765
    Abstract: Saliva offers an alternative specimen for the therapeutic monitoring of cyclosporine (CsA) in children and patients with difficult venous access. For a highly protein-bound drug such as CsA, saliva provides a practical approach for measuring the unbound concentration. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is ideally suited for the measurement of drugs in saliva. A solid-phase extraction technique, analytic liquid chromatography over an Aqua Perfect column, maintained at 65° C., and electrospray tandem mass spectrometry were used to quantify CsA in saliva. The method used cyclosporine C (CsC) as the internal standard. Mobile phase comprised of a 97:3 voL mixture of methanol and 30 mmol/L ammonium acetate at a flow rate of 0.5 mL/min. Chromatograms using mass transitions of m/z 1219.9?m/z 1202.9 for CsA and m/z 1235.9?m/z 1218.9 for CsC were obtained. The calibration curve was linear from 1 to 300 ?g/L with correlation coefficient values ranging from 0.9732 to 0.9968).
    Type: Application
    Filed: November 16, 2007
    Publication date: October 16, 2008
    Inventors: Fatemeh Akhlaghi, Anisha E. Mendonza